Renaissance Technologies
DTIL icon

Renaissance Technologies’s Precision BioSciences DTIL Stock Holding History

Renaissance Technologies’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$539K Sell
68,577
-154,600
-69% -$1.09M ﹤0.01% 2579
2026
Q1 		$1.23M Sell
223,177
-103,300
-32% -$477K ﹤0.01% 2156
2025
Q4 		$1.36M Buy
326,477
+130,300
+66% +$740K ﹤0.01% 2101
2025
Q3 		$1.08M Buy
196,177
+115,900
+144% +$555K ﹤0.01% 2445
2025
Q2 		$337K Sell
80,277
-2,700
-3% -$13.3K ﹤0.01% 3000
2025
Q1 		$396K Sell
82,977
-26,821
-24% -$137K ﹤0.01% 2828
2024
Q4 		$418K Buy
109,798
+29,200
+36% +$213K ﹤0.01% 2922
2024
Q3 		$722K Sell
80,598
-2,400
-3% -$23.1K ﹤0.01% 2616
2024
Q2 		$808K Sell
82,998
-16,500
-17% -$194K ﹤0.01% 2448
2024
Q1 		$1.35M Buy
99,498
+13,124
+15% +$161K ﹤0.01% 2292
2023
Q4 		$946K Buy
86,374
+33,305
+63% +$359K ﹤0.01% 2442
2023
Q3 		$543K Sell
53,069
-4,153
-7% -$63.8K ﹤0.01% 2671
2023
Q2 		$903K Buy
57,222
+6,344
+12% +$145K ﹤0.01% 2533
2023
Q1 		$1.15M Sell
50,878
-1,813
-3% -$59.7K ﹤0.01% 2384
2022
Q4 		$1.88M Sell
52,691
-19,731
-27% -$780K ﹤0.01% 2108
2022
Q3 		$2.82M Buy
72,422
+42,196
+140% +$2M ﹤0.01% 1799
2022
Q2 		$1.45M Buy
30,226
+22,447
+289% +$1.32M ﹤0.01% 2435
2022
Q1 		$719K Buy
7,779
+7,099
+1,044% +$965K ﹤0.01% 2951
2021
Q4 		$151K Buy
+680
New +$190K ﹤0.01% 3604
2021
Q3 		– Sell
-3,371
Closed -$1.27M – 3545
2021
Q2 		$1.27M Sell
3,371
-844
-20% -$253K ﹤0.01% 2545
2021
Q1 		$1.31M Buy
4,215
+2,977
+240% +$1.04M ﹤0.01% 2483
2020
Q4 		$310K Buy
+1,238
New +$303K ﹤0.01% 3019
2020
Q2 		– Sell
-2,988
Closed -$541K – 3513
2020
Q1 		$541K Buy
+2,988
New +$782K ﹤0.01% 2724

Other funds holding DTIL

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
EAM
Empery Asset Management New York $86.5M AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Renaissance Technologies's DTIL Position: Q2 2026 in Review

Renaissance Technologies reduced its Precision BioSciences (DTIL) stake by 69% in Q2 2026, selling an estimated $1.09M and leaving 68,577 shares worth $539K. The position accounts for ﹤0.01% of the portfolio, ranked #2579.

Renaissance Technologies first reported a position in DTIL in Q1 2020 and has held it in 23 quarters since. The position peaked at $2.82M in Q3 2022. 95 funds tracked by Wall St. Rank hold DTIL as of Q2 2026.

  • Renaissance Technologies held 68,577 shares of Precision BioSciences worth $539K as of Q2 2026.
  • Renaissance Technologies sold 154,600 Precision BioSciences shares in Q2 2026, an estimated $1.09M.
  • Precision BioSciences made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2579 holding.
  • Renaissance Technologies first reported a position in Precision BioSciences in Q1 2020 and has held it in 23 quarters since.
  • Renaissance Technologies's Precision BioSciences position peaked at $2.82M in Q3 2022.
  • 95 funds tracked by Wall St. Rank held Precision BioSciences as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.